Quantum Biopharma (QNTM) Assets Average (2024 - 2026)
Quantum Biopharma (QNTM) posted Assets Average of $13.0 million for Q1 2026, up 3.05% sequentially from $12.7 million in Q4 2025, and down 18.46% YoY from $16.0 million in Q1 2025.
Quantum Biopharma (QNTM) Assets Average (2024 - 2026) Analysis & Trends
Quantum Biopharma has reported Assets Average for 3 years, with the latest figure at $13.0 million in Q1 2026.
- Quarterly Assets Average fell 18.46% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (down 18.46% YoY) and the FY2025 annual result came in at $14.1 million, down 18.25% from the prior year.
- Assets Average improved to $13.0 million in Q1 2026 per QNTM's latest filing, from $12.7 million in the prior quarter.
- Over five years, Assets Average peaked at $18.1 million in Q4 2024 and troughed at $12.7 million in Q4 2025.
- A 3-year average of $15.2 million and a median of $15.1 million in 2025 frame the typical range for Assets Average.
- The widest YoY moves for Assets Average: up 14.07% in 2025, down 29.97% in 2025.
- Over 3 years, Assets Average stood at $18.1 million in 2024, then slipped by 29.97% to $12.7 million in 2025, then gained by 3.05% to $13.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $13.0 million, $12.7 million, and $14.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 14.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.66 Mn |
| Mar 31, 2026 | 13.04 Mn |
| Dec 31, 2025 | 12.66 Mn |
| Sep 30, 2025 | 14.73 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 18.07 Mn |
| Sep 30, 2024 | 17.14 Mn |